⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5200380 | 0.90 | PPARA (0.50) | — | |
| SCHEMBL483132 | 0.83 | — | — | |
| SCHEMBL27578660 | 0.77 | PPARA (0.33) | — | |
| SCHEMBL1678870 | 0.76 | — | — | |
| SCHEMBL3373286 | 0.76 | TSHR (0.46) | — | |
| SCHEMBL1794509 | 0.75 | PPARA (0.46) | — | |
| SCHEMBL27576164 | 0.75 | PPARA (0.32) | — | |
| SCHEMBL8672401 | 0.74 | — | — | |
| SCHEMBL101407 | 0.74 | — | — | |
| SCHEMBL104706 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107602620-B | Novel iridium-based complexes for ECL | 霍夫曼-拉罗奇有限公司 | 2020-08-28 | — | — | CN | claimed |
| CN-107602620-A | Novel iridium base complex for ECL | 霍夫曼-拉罗奇有限公司 | 2018-01-19 | — | — | CN | claimed |
| EP-2880043-B1 | NEW BIS-IRIDIUM-COMPLEXES FOR MANUFACTURING OF ECL-LABELS | ROCHE DIAGNOSTICS GMBH (DE) | 2016-09-21 | — | — | EP | claimed |
| EP-2880043-A1 | NEW BIS-IRIDIUM-COMPLEXES FOR MANUFACTURING OF ECL-LABELS | Roche Diagnostics GmbH (DE) | 2015-06-10 | — | — | EP | claimed |
| US-20150148536-A1 | NEW BIS-IRIDIUM-COMPLEXES FOR MANUFACTURING OF ECL-LABELS | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (DE) | 2015-05-28 | — | — | US | claimed |
| WO-2014019710-A1 | NEW BIS-IRIDIUM-COMPLEXES FOR MANUFACTURING OF ECL-LABELS | ROCHE DIAGNOSTICS GMBH (DE) | 2014-02-06 | — | — | WO | claimed |
| EP-4373493-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH ENHANCED IMID ACTIVITY | Nurix Therapeutics, Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-4370123-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY | Nurix Therapeutics, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024086296-A1 | COMPOUNDS USEFUL IN MODULATING EGFR AND PI3K | MEKANISTIC THERAPEUTICS LLC (US) | 2024-04-25 | — | — | WO | disclosed |
| US-20240124475-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY | NURIX THERAPEUTICS, INC. | 2024-04-18 | — | — | US | disclosed |
| US-20240092766-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMA (US) | 2024-03-21 | — | — | US | disclosed |
| EP-4334302-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS, COMPRISING THE SAME, METHODS OF THEIR MAKING, AND METHODS OF THEIR USE | Nurix Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4334303-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | Nurix Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| US-20070043023-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2007-02-22 | — | — | US | disclosed |
| WO-2007022459-A2 | PROCESSES AND INTERMEDIATES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007016589-A2 | INHIBITORS OF SERINE PROTEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-02-08 | — | — | WO | disclosed |
| WO-2006127588-A2 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006105035-A2 | MUSCARINIC MODULATORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-10-05 | — | — | WO | disclosed |
| CN-1692101-A | 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors | JAPAN TOBACCO INC (JP) | 2005-11-02 | — | — | CN | disclosed |
| US-4156732-A | Certain pharmaceutical sulfamoylbenzoyl benzofurans, benzothiophenes, and indoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-05-29 | — | — | US | disclosed |